Nucleic Acid Amplification-Free Digital Detection Method for SARS-CoV-2 RNA Based on Droplet Microfluidics and CRISPR–Cas13a
Analytical Chemistry · 14.11.2023 · 95 (45) · 16489-16495
DOI: 10.1021/acs.analchem.3c02007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, online erschienen am 01.11.2023. Verfasst von Xiaoyun Shan und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemistry and Molecular Sciences, Wuhan University, Wuhan 430072, China. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Most of the methods currently developed for RNA detection based on CRISPR were combined with nucleic acid amplification. As a result, such methods inevitably led to certain disadvantages such as multiple operations, expensive reagents, and amplification bias. To solve the above problems, we developed a highly sensitive and specific nucleic acid amplification-free digital detection method for SARS-CoV-2 RNA based on droplet microfluidics and CRISPR-Cas13a. In this assay, thousands of monodisperse droplets with a size of 30 μm were generated within 2 min by a negative pressure-driven microfluidic chip. By confining a single target RNA recognition event to an independent droplet, the collateral cleavage products of activated Cas13a could be accumulated in one droplet. By combining the droplet microfluidics and CRISPR-Cas13a, SARS-CoV-2 RNA could be easily detected within 30 min with a detection limit of 470 aM. The performance of this assay was verified by specificity experiments and spiking and recovery experiments with human saliva. Compared with many developed methods for SARS-CoV-2 RNA detection, our method is time- and reagent-saving and easy to operate. Taken together, this digital detection method based on droplet microfluidics and CRISPR-Cas13a provides a promising approach for RNA detection in clinical diagnostics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Chemistry and Molecular Sciences, Wuhan University, Wuhan 430072, China.
- Wuhan Research Center for Infectious Diseases and Cancer, Chinese Academy of Medical Sciences, Wuhan 430071, China.
ORCID-Profile: Zhike He
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Shan, X., Gong, F., Yang, Y., Qian, J., Tan, Z., Tian, S., He, Z., & Ji, X. (2023). Nucleic Acid Amplification-Free Digital Detection Method for SARS-CoV-2 RNA Based on Droplet Microfluidics and CRISPR–Cas13a. Analytical Chemistry, 95(45), 16489-16495. https://doi.org/10.1021/acs.analchem.3c02007
Vancouver
Shan X, Gong F, Yang Y, Qian J, Tan Z, Tian S, et al. Nucleic Acid Amplification-Free Digital Detection Method for SARS-CoV-2 RNA Based on Droplet Microfluidics and CRISPR–Cas13a. Analytical Chemistry. 2023;95(45):16489-16495. doi:10.1021/acs.analchem.3c02007
BibTeX
@article{Shan2023,
author = {Shan, Xiaoyun and Gong, Feng and Yang, Yixia and Qian, Jingjing and Tan, Zhiyou and Tian, Songbai and He, Zhike and Ji, Xinghu},
title = {Nucleic Acid Amplification-Free Digital Detection Method for SARS-CoV-2 RNA Based on Droplet Microfluidics and CRISPR–Cas13a},
journal = {Analytical Chemistry},
year = {2023},
volume = {95},
number = {45},
pages = {16489--16495},
doi = {10.1021/acs.analchem.3c02007}
}
EUVIMED